Date published: 2026-5-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

DSCD75 Inhibitors

DSCD75 inhibitors are a class of chemical compounds that function by inhibiting the enzymatic activity of DSCD75, a protein implicated in various cellular pathways. The precise molecular structure of these inhibitors often incorporates specific motifs designed to interact with the active site of the DSCD75 enzyme, blocking its normal catalytic function. These inhibitors typically operate by either binding directly to the enzyme's active site or by altering its conformation in a manner that impairs substrate binding or product release. Structural characteristics of DSCD75 inhibitors often include polar functional groups that engage in hydrogen bonding or hydrophobic interactions, which stabilize their association with the enzyme. Depending on their chemical makeup, DSCD75 inhibitors can exhibit reversible or irreversible modes of inhibition, governed by the nature of the interaction with the enzyme's catalytic residues.

From a chemical perspective, the development of DSCD75 inhibitors involves fine-tuning their molecular properties, such as lipophilicity, polarity, and molecular weight, to ensure optimal interaction with the enzyme. Advanced synthetic chemistry techniques are employed to create variations of the inhibitors with different substituent groups, providing insights into structure-activity relationships. Computational methods, such as molecular docking and dynamics simulations, are often used to predict how DSCD75 inhibitors might interact with the enzyme at an atomic level. Crystallographic studies further provide detailed information on the binding mode of these inhibitors, allowing researchers to optimize chemical designs for enhanced selectivity and potency. Such studies are essential for understanding the fundamental biochemistry of DSCD75 and its role in cellular processes, providing a rich field for exploring enzymatic regulation through chemical inhibition.

SEE ALSO...

Items 1 to 10 of 17 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fenofibrate

49562-28-9sc-204751
5 g
$41.00
9
(1)

Activates peroxisome proliferator-activated receptor alpha (PPARα), influencing lipid metabolism.

Lipase Inhibitor, THL

96829-58-2sc-203108
50 mg
$52.00
7
(1)

Inhibits gastrointestinal lipases, reducing fat absorption, and may indirectly affect lipid metabolism.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

As a PPARγ agonist, rosiglitazone modifies lipid and glucose metabolism, which could indirectly impact THEM6.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$257.00
$505.00
9
(1)

A statin that inhibits HMG-CoA reductase, potentially affecting lipid synthesis and metabolism.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Activates PPARγ, influencing lipid metabolism and insulin sensitivity.

Nicotinic Acid

59-67-6sc-205768
sc-205768A
250 g
500 g
$62.00
$124.00
1
(1)

Lowers LDL cholesterol and triglycerides, possibly influencing lipid metabolism pathways.

Ezetimibe

163222-33-1sc-205690
sc-205690A
25 mg
100 mg
$96.00
$241.00
12
(2)

Inhibits intestinal absorption of cholesterol, potentially affecting lipid homeostasis.

Bezafibrate

41859-67-0sc-204650B
sc-204650
sc-204650A
sc-204650C
500 mg
1 g
5 g
10 g
$31.00
$46.00
$122.00
$204.00
5
(1)

Bezafibrate activates PPARs and influences lipid metabolism, potentially affecting THEM6.

Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3)

6217-54-5sc-200768
sc-200768A
sc-200768B
sc-200768C
sc-200768D
100 mg
1 g
10 g
50 g
100 g
$94.00
$210.00
$1779.00
$8021.00
$16657.00
11
(1)

Have roles in altering lipid profiles, which could indirectly influence lipid metabolism.

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$66.00
$267.00
2
(2)

Another PPARα activator, altering lipid profiles and potentially affecting lipid metabolism.